Asthma Clinical Trials in Philadelphia

Showing 181-200 of 204 trials

Effectiveness and Safety Study for JNJ-18054478 in Asthma Patients.

NCT00530166

The purpose of this study is to assess the effectiveness of JNJ-18054478 measured by the percent change from baseline in Forced Expiratory Volume in one Second (FEV1) after 12 weeks of therapy in patients with persistent asthma.

Asthma

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.26 participantsStarted Jul 2007

Scottsdale, Arizona, United States • Long Beach, California, United States • Los Angeles, California, United States +33 more locations

COMPLETEDPHASE2< 1 mile

Study Evaluating the Safety and Efficacy of MN-221 as an Adjunct to Standard Therapy in Subjects Experiencing an Acute Exacerbation of Asthma

NCT00838591

The objective of this clinical study is to examine the safety and effectiveness of intravenous MN-221 compared to placebo when administered as an adjunct to standard therapy in subjects experiencing an acute exacerbation of asthma.

Asthma

MediciNova176 participantsStarted Mar 2009

Loma Linda, California, United States • San Diego, California, United States • San Diego, California, United States +12 more locations

Effectiveness and Safety Study for JNJ-18054478 in Asthma Patients.

Study Evaluating the Safety and Efficacy of MN-221 as an Adjunct to Standard Therapy in Subjects Experiencing an Acute Exacerbation of Asthma

Asthma Trials in Other Cities

Study of Acid Reflux in Asthma

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Reliability of a Top Mount Actuation Indicator With Levalbuterol MDI in Adult and Pediatric Subjects With Asthma or COPD

Evaluate the Effect of Omalizumab on Markers of Asthma Impairment in Patients With Persistent Allergic Asthma

Oral Prednisolone Dosing in Children Hospitalized With Asthma

Efficacy, Safety and Pharmacokinetics of Different Regimens of Indacaterol

Investigation of Efficacy, Safety and Tolerability of Once and Twice Daily Doses of AZD1981 in Asthmatic Patients

A Two-week Study Assessing the Onset of Effect Questionnaire (OEQ) Administered Daily Versus Weekly in Adult Subjects

Effect of a Community-based Nursing Intervention on Mortality in Chronically Ill Older Adults

Study of Daclizumab in Patients With Chronic, Persistent Asthma

Pilot Study in Patients With Symptomatic Steroid-Naive Asthma

Efficacy of Ciclesonide Versus Placebo Administered Either as Once Daily or Twice Daily in Patients Treated Previously With an Inhaled Corticosteroid

Anti-TF Antibody (ALT-836) to Treat Septic Patients With Acute Lung Injury or Acute Respiratory Distress Syndrome

Calfactant for Direct Acute Respiratory Distress Syndrome

Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma

Safety and Tolerability Study to Evaluate MEDI-534 in Children 6 to < 24 Months of Age

Safety and Tolerability Study of Levalbuterol HFA Compared to Racemic Albuterol HFA in Subjects With Asthma

Study Evaluating the Safety and Effects of MN-221 in Subjects With Moderate to Severe Asthma

Other Conditions in Philadelphia